KALEY BERTRAND: Open Payments
NPI 1346912821 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,205 in 52 payments from 16 companies in 2025. Trend: 2023 $225 · 2024 $308 · 2025 $1,205
Food & beverage: $1,205
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $368 |
| AstraZeneca Pharmaceuticals LP | 6 | $216 |
| ABBVIE INC. | 15 | $187 |
| Lilly USA, LLC | 3 | $62 |
| Dexcom, Inc. | 3 | $58 |
| Astellas Pharma US Inc | 2 | $56 |
| Exact Sciences Corporation | 2 | $38 |
| Eisai Inc. | 1 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Amgen Inc. | 2 | $30 |
Products named: Wegovy, Ozempic, FARXIGA, VRAYLAR, MOUNJARO, Dexcom G6 Transmitter, Veozah, QULIPTA.
Industry payments across AZ — which companies pay providers there.
